Merck’s Vaccine Division President, Julie Gerberding, Sells $9.1 Million in Shares—Is She Jumping Ship?

By Robert F. Kennedy, Jr., Chairman, CHD

Last month Cancer Research UK announced an alarming 54% rise in cervical cancer among 24-29-year-olds, the first generation to receive the HPV jabs. The following day, the Journal of the Royal Society of Medicine published a withering critique of Gardasil’s crooked clinical trials: “It is still uncertain whether human papillomavirus (HPV) vaccination prevents cervical cancer as trials were not designed to detect this outcome.” Also in January, SEC filings reveal that Merck’s Vaccine Division President Julie Gerberding sold over half her Merck shares for $9.1 Million.

Merck is now fighting existential fraud lawsuits, on both the MMR and Gardasil vaccines, that threaten licensing for those key products. What else does Gerberding know?

READ MORE
 

EPIC EPA Fail  - A Thorough Assessment of the EPA's Not-So-Thorough-Assessment of Glyphosate

By Zen Honeycutt, Director, Moms Across America

Glyphosate-based herbicides are the most widely used herbicides in the world. According to the EPA’s own study, between 2012 to 2016 approximately 281 million pounds of glyphosate was applied to 298 million acres annually in agricultural settings, on average.

Yet, despite massive public outcry, letters to the EPA, thousands of calls, protests, petitions, and campaigns regarding the myriad of ways glyphosate has been shown to impact human health, the EPA released a statement on January 30, 2020:

The EPA thoroughly assessed risks to humans from exposure to glyphosate from all registered uses and all routes of exposure and did not identify any risks of concern. 

How can the EPA justify this?

READ MORE
 

You Make It Possible!

Children's Health Defense depends on
generous donations from our community.
Large or small, every donation gets us
closer to achieving our goals. Listen to
what RFK, Jr. has to say in the video
at the link below.